The company have demonstrably boosted its progress of a novel solution for ATTR-CM, employing Attruby. Initial clinical data indicates potential improvements for those suffering with a debilitating disease. This focus highlights BridgeBio's focus to treating unmet healthcare requirements in this heart field. Attruby: BridgeBio's Novel A… Read More